心臟生物标记市场规模 - 按产品（肌钙蛋白、CK-MB、肌红蛋白、利钠肽、CRP、缺血修饰白蛋白）、应用、最终用途 - 全球预测，2023-2032 年

2023年至2032年，心臟生物标记市场规模预计将达到12.8%的CAGR。全球心血管疾病盛行率不断上升，加上人口老化，刺激了对先进诊断工具的需求。根据世界心臟联盟（WHF）的最新报告，2021年有近2,050万人死于心血管疾病（CVD）。

尖端技术的出现和对早期检测的日益重视提高了心臟生物标记在临床实践中的重要性。这些生物标记，从蛋白质到遗传标记物，正在成为医疗保健专业人员预测、诊断和管理心血管疾病不可或缺的工具，从而重塑心臟护理的模式。

心臟生物标记市场根据产品、应用、最终用途和地区进行分类。

预计到2032 年，利钠肽领域将产生大量收入。利钠肽，特别是B 型利钠肽(BNP) 和N 末端B 型利钠肽原(NT-proBNP)，已成为心臟衰竭的关键指标。这些胜肽在检测心臟压力和功能障碍方面的精确度和敏感性引起了医疗保健提供者的广泛关注。随着技术的进步，新型利尿钠肽检测方法的开发有望提高诊断准确性，为临床医生提供强大的早期介入和个人化治疗策略。

受全球心臟衰竭流行的推动，到 2032 年，充血性心臟衰竭 (CHF) 应用领域将对心臟生物标记产生大量需求。随着 CHF 病例数量的惊人增加，CHF 生物标记谱，包括肌钙蛋白、肌酸激酶-MB (CK-MB) 和肌红蛋白，有助于心臟功能的全面评估。将这些生物标记整合到常规临床实践中正在重塑心臟衰竭的治疗方法，以实现及时干预并改善患者预后。

欧洲心臟生物标记产业预计在 2023 年至 2032 年期间将录得强劲的CAGR，这得益于心血管护理范式转变，并且越来越重视预防措施和个人化医疗。在医疗机构和创新诊断公司之间的合作推动下，产品融入常规临床实践的势头正在增强。随着欧洲地区继续拥抱最新进展，市场预计将持续成长，开创整个欧洲大陆心血管保健的新时代。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：心臟生物标记产业见解

• COVID-19 影响分析
• 产业生态系统分析
• 技术景观
• 监管环境
• 产业影响力
  • 成长动力
    • 心血管疾病盛行率增加
    • 老年人口的增加导致心臟相关疾病的盛行率更高
    • 不断增加的临床研究旨在发现新的心臟生物标记
    • 增加即时检测
  • 产业陷阱与挑战
    • 严格的监管框架
    • 心臟影像技术的存在与进步
• 成长潜力分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
  • Abbott Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：心臟生物标记市场规模与预测：按产品划分，2018-2032 年

• 主要动向：按产品
• 肌钙蛋白
• 肌酸激酶-MB (CK-MB)
• 肌红蛋白
• 利钠肽
• C反应蛋白（CRP）
• 缺血修饰白蛋白
• 其他产品

第 6 章：心臟生物标记市场规模和预测：按应用，2018-2032

• 主要动向：按应用
• 充血性心臟衰竭
• 心肌梗塞
• 急性冠状动脉综合症
• 动脉粥状硬化
• 其他应用

第 7 章：心臟生物标记市场规模与预测：依最终用途，2018-2032 年

• 主要动向：依最终用途
• 医院实验室
• 护理点测试设施
• 诊断设施
• 其他最终用户

第 8 章：心臟生物标记市场规模与预测：按地区划分，2018-2032 年

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Abbott Diagnostics
• Roche Diagnostics
• Siemens Healthineers
• Beckman Coulter
• Bio-Rad Laboratories
• Ortho Clinical Diagnostics
• Randox Laboratories
• Quidel Corporation
• Radiometer
• Tosoh Corporation
• Meso Scale Diagnostics (MSD)
• Thermo Fisher Scientific
• Luminex Corporation
• Trinity Biotech
• Biomerieux

Cardiac biomarkers market size is expected to record 12.8% CAGR from 2023 to 2032. The rising prevalence of cardiovascular diseases worldwide, coupled with an aging population, has spurred the need for advanced diagnostic tools. According to a new report from the World Heart Federation (WHF), nearly 20.5 million deaths happened due to cardiovascular (CVD) in 2021.

The advent of cutting-edge technologies and the growing emphasis on early detection have elevated the importance of cardiac biomarkers in clinical practice. These biomarkers, ranging from proteins to genetic markers, are becoming indispensable tools for healthcare professionals in predicting, diagnosing, and managing cardiovascular conditions, thus reshaping the landscape of cardiac care.

The cardiac biomarkers market is classified based on product, application, end-use, and region.

The natriuretic peptides segment is predicted to generate massive revenues by 2032. Natriuretic peptides, particularly B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), have become pivotal indicators for heart failure. The precision and sensitivity of these peptides in detecting cardiac stress and dysfunction have garnered widespread attention from healthcare providers. As technology advances, the development of novel natriuretic peptide assays promises enhanced diagnostic accuracy, providing clinicians with a powerful arsenal for early intervention and personalized treatment strategies.

The Congestive Heart Failure (CHF) application segment will generate high demand for cardiac biomarkers through 2032, driven by the global epidemic of heart failure. With a staggering rise in the number of CHF cases, the spectrum of CHF biomarkers, including troponins, creatine kinase-MB (CK-MB), and myoglobin, aid in the comprehensive evaluation of cardiac function. The integration of these biomarkers into routine clinical practice is reshaping the approach of managing heart failure, enabling timely interventions and improving patient outcomes.

Europe cardiac biomarkers industry is anticipated to record strong CAGR from 2023 to 2032, favored by a paradigm shift in cardiovascular care, with an increasing emphasis on preventive measures and personalized medicine. The product integration into routine clinical practice is gaining momentum, driven by collaborative efforts between healthcare institutions and innovative diagnostic companies. As the Europe region continues to embrace the latest advancements, the market is poised for sustained growth, ushering in a new era of cardiovascular healthcare across the continent.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & workings
• 1.3 Forecast calculations
• 1.4 Data Sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global cardiac biomarkers market 360 degree synopsis, 2018 - 2032
• 2.2 Regional trends
• 2.3 Product trends
• 2.4 Application trends
• 2.5 End-use trends

Chapter 3 Cardiac Biomarkers Industry Insights

• 3.1 COVID- 19 impact analysis
• 3.2 Industry ecosystem analysis
• 3.3 Technology landscape
• 3.4 Regulatory landscape
• 3.5 Industry impact forces
  • 3.5.1 Growth drivers
    • 3.5.1.1 Increase in prevalence of cardiovascular diseases
    • 3.5.1.2 Rise in the elderly population is leading to a higher prevalence of heart-related conditions
    • 3.5.1.3 Rising clinical research studies aimed at discovering new cardiac biomarkers
    • 3.5.1.4 Increase in point-of-care testing
  • 3.5.2 Industry pitfalls & challenges
    • 3.5.2.1 Stringent regulatory frameworks
    • 3.5.2.2 Presence and advancement in cardiac imaging technologies
• 3.6 Growth potential analysis
  • 3.6.1 By product
  • 3.6.2 By application
  • 3.6.3 By end-use
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Abbott Diagnostics
  • 4.1.2 Roche Diagnostics
  • 4.1.3 Siemens Healthineers
• 4.2 Competitive analysis of major market players, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic outlook matrix, 2022

Chapter 5 Cardiac Biomarkers Market Size and Forecast, By Product, 2018-2032 (USD Million)

• 5.1 Key trends, by product
• 5.2 Troponins
• 5.3 Creatine kinase-MB (CK-MB)
• 5.4 Myoglobin
• 5.5 Natriuretic peptides
• 5.6 C-reactive protein (CRP)
• 5.7 Ischemia modified albumin
• 5.8 Other products

Chapter 6 Cardiac Biomarkers Market Size and Forecast, By Application, 2018-2032 (USD Million)

• 6.1 Key trends, by application
• 6.2 Congestive heart failure
• 6.3 Myocardial infarction
• 6.4 Acute coronary syndrome
• 6.5 Atherosclerosis
• 6.6 Other applications

Chapter 7 Cardiac Biomarkers Market Size and Forecast, By End-use, 2018-2032 (USD Million)

• 7.1 Key trends, by end-use
• 7.2 Hospital laboratory
• 7.3 Point of care testing facilities
• 7.4 Diagnostic facilities
• 7.5 Other end-users

Chapter 8 Cardiac Biomarkers Market Size and Forecast, By Region, 2018-2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Abbott Diagnostics
• 9.2 Roche Diagnostics
• 9.3 Siemens Healthineers
• 9.4 Beckman Coulter
• 9.5 Bio-Rad Laboratories
• 9.6 Ortho Clinical Diagnostics
• 9.7 Randox Laboratories
• 9.8 Quidel Corporation
• 9.9 Radiometer
• 9.10 Tosoh Corporation
• 9.11 Meso Scale Diagnostics (MSD)
• 9.12 Thermo Fisher Scientific
• 9.13 Luminex Corporation
• 9.14 Trinity Biotech
• 9.15 Biomerieux

Data Tables

• TABLE 1 Industry impact forces
• TABLE 2 Competitive analysis of major market players
• TABLE 3 Competitive positioning matrix: Classification criteria
• TABLE 4 Troponins market size, 2018 - 2024 (USD Million)
• TABLE 5 Troponins market size, 2025 - 2032 (USD Million)
• TABLE 6 CK-MB market size, 2018 - 2024 (USD Million)
• TABLE 7 CK-MB market size, 2025 - 2032 (USD Million)
• TABLE 8 Myoglobin market size, 2018 - 2024 (USD Million)
• TABLE 9 Myoglobin market size, 2025 - 2032 (USD Million)
• TABLE 10 Natriuretic peptides market size, 2018 - 2024 (USD Million)
• TABLE 11 Natriuretic peptides market size, 2025 - 2032 (USD Million)
• TABLE 12 CRP market size, 2018 - 2024 (USD Million)
• TABLE 13 CRP market size, 2025 - 2032 (USD Million)
• TABLE 14 Ischemia modified albumin market size, 2018 - 2024 (USD Million)
• TABLE 15 Ischemia modified albumin market size, 2025 - 2032 (USD Million)
• TABLE 16 Other products market size, 2018 - 2024 (USD Million)
• TABLE 17 Other products market size, 2025 - 2032 (USD Million)
• TABLE 18 Congestive heart failure market size, 2018 - 2024 (USD Million)
• TABLE 19 Congestive heart failure market size, 2025 - 2032 (USD Million)
• TABLE 20 Myocardial infarction market size, 2018 - 2024 (USD Million)
• TABLE 21 Myocardial infarction market size, 2025 - 2032 (USD Million)
• TABLE 22 Acute coronary syndrome market size, 2018 - 2024 (USD Million)
• TABLE 23 Acute coronary syndrome market size, 2025 - 2032 (USD Million)
• TABLE 24 Atherosclerosis market size, 2018 - 2024 (USD Million)
• TABLE 25 Atherosclerosis market size, 2025 - 2032 (USD Million)
• TABLE 26 Other application market size, 2018 - 2024 (USD Million)
• TABLE 27 Other application market size, 2025 - 2032 (USD Million)
• TABLE 28 Hospital laboratory market size, 2018 - 2024 (USD Million)
• TABLE 29 Hospital laboratory market size, 2025 - 2032 (USD Million)
• TABLE 30 Point of care testing facilities market size, 2018 - 2024 (USD Million)
• TABLE 31 Point of care testing facilities market size, 2025 - 2032 (USD Million)
• TABLE 32 Diagnostic facilities market size, 2018 - 2024 (USD Million)
• TABLE 33 Diagnostic facilities market size, 2025 - 2032 (USD Million)
• TABLE 34 Other end-users market size, 2018 - 2024 (USD Million)
• TABLE 35 Other end-users market size, 2025 - 2032 (USD Million)
• TABLE 36 North America cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 37 North America cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 38 North America cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 39 North America cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 40 North America cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 41 North America cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 42 North America cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 43 North America cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 44 U.S. cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 45 U.S. cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 46 U.S. cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 47 U.S. cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 48 U.S. cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 49 U.S. cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 50 Canada cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 51 Canada cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 52 Canada cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 53 Canada cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 54 Canada cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 55 Canada cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 56 Europe cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 57 Europe cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 58 Europe cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 59 Europe cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 60 Europe cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 61 Europe cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 62 Europe cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 63 Europe cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 64 Germany cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 65 Germany cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 66 Germany cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 67 Germany cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 68 Germany cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 69 Germany cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 70 UK cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 71 UK cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 72 UK cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 73 UK cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 74 UK cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 75 UK cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 76 France cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 77 France cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 78 France cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 79 France cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 80 France cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 81 France cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 82 Italy cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 83 Italy cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 84 Italy cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 85 Italy cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 86 Italy cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 87 Italy cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 88 Spain cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 89 Spain cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 90 Spain cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 91 Spain cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 92 Spain cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 93 Spain cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 94 Rest of Europe cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 95 Rest of Europe cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 96 Rest of Europe cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 97 Rest of Europe cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 98 Rest of Europe cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 99 Rest of Europe cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 100 Asia Pacific cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 101 Asia Pacific cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 102 Asia Pacific cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 103 Asia Pacific cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 104 Asia Pacific cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 105 Asia Pacific cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 106 Asia Pacific cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 107 Asia Pacific cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 108 China cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 109 China cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 110 China cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 111 China cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 112 China cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 113 China cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 114 Japan cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 115 Japan cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 116 Japan cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 117 Japan cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 118 Japan cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 119 Japan cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 120 India cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 121 India cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 122 India cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 123 India cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 124 India cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 125 India cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 126 Australia cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 127 Australia cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 128 Australia cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 129 Australia cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 130 Australia cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 131 Australia cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 132 South Korea cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 133 South Korea cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 134 South Korea cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 135 South Korea cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 136 South Korea cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 137 South Korea cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 138 Rest of Asia Pacific cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 139 Rest of Asia Pacific cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 140 Rest of Asia Pacific cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 141 Rest of Asia Pacific cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 142 Rest of Asia Pacific cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 143 Rest of Asia Pacific cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 144 Latin America cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 145 Latin America cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 146 Latin America cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 147 Latin America cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 148 Latin America cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 149 Latin America cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 150 Latin America cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 151 Latin America cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 152 Brazil cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 153 Brazil cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 154 Brazil cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 155 Brazil cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 156 Brazil cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 157 Brazil cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 158 Mexico cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 159 Mexico cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 160 Mexico cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 161 Mexico cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 162 Mexico cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 163 Mexico cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 164 Argentina cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 165 Argentina cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 166 Argentina cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 167 Argentina cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 168 Argentina cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 169 Argentina cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 170 Rest of Latin America cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 171 Rest of Latin America cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 172 Rest of Latin America cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 173 Rest of Latin America cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 174 Rest of Latin America cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 175 Rest of Latin America cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 176 Middle East & Africa cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 177 Middle East & Africa cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 178 Middle East & Africa cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 179 Middle East & Africa cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 180 Middle East & Africa cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 181 Middle East & Africa cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 182 Middle East & Africa cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 183 Middle East & Africa cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 184 Saudi Arabia cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 185 Saudi Arabia cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 186 Saudi Arabia cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 187 Saudi Arabia cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 188 Saudi Arabia cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 189 Saudi Arabia cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 190 South Africa cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 191 South Africa cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 192 South Africa cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 193 South Africa cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 194 South Africa cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 195 South Africa cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 196 UAE cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 197 UAE cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 198 UAE cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 199 UAE cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 200 UAE cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 201 UAE cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 202 Rest of Middle East & Africa cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 203 Rest of Middle East & Africa cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 204 Rest of Middle East & Africa cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 205 Rest of Middle East & Africa cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 206 Rest of Middle East & Africa cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 207 Rest of Middle East & Africa cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)

Charts & Figures

• FIG. 1 Research design
• FIG. 2 Data collection techniques
• FIG. 3 Primary research process
• FIG. 4 Market sizing approach
• FIG. 5 Forecasting model
• FIG. 6 Global industry snapshot
• FIG. 7 Industry ecosystem analysis
• FIG. 8 Growth potential analysis, by product
• FIG. 9 Growth potential analysis, by application
• FIG. 10 Growth potential analysis, by end-use
• FIG. 11 Porter's analysis
• FIG. 12 PESTEL analysis
• FIG. 13 Company market share analysis, 2022
• FIG. 14 Competitive analysis of major market players, 2022
• FIG. 15 Competitive positioning matrix, 2022
• FIG. 16 Strategic outlook matrix, 2022